US Government Plays the Anthrax Card

On Monday October 6th, a entry into the Federal Register went a little like this:

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Declaration pursuant to section 319F-3 of the Public Health Service Act (42 U.S.C. 247d-6d) to provide targeted liability protections for anthrax countermeasures based on a credible risk that the threat of exposure to Bacillus anthracis and the resulting disease constitutes a public health emergency.

DATES: This notice and the attached declaration are effective as of the date of signature of the declaration.

FOR FURTHER INFORMATION CONTACT: RADM W.C. Vanderwagen, Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services, 200 Independence Avenue, SW., Washington, DC 20201, Telephone (202) 205-2882 (this is not a toll-free number).

HHS Secretary's Declaration for Utilization of Public Readiness and Emergency Preparedness Act for Anthrax Countermeasures (emphasis added - G)

Whereas significant changes in the nature, regularity and degree of threats to health posed by the use of infectious agents as weapons of biological warfare have generated increased concern for the safety of the general American population particularly following the deliberate exposure of citizens in the

[[Page 58240]]

United States to Bacillus anthracis (B. anthracis) spores in 2001 that demonstrated the ease of dissemination, infectivity, and mortality; Whereas the Secretary of Homeland Security has determined that B. anthracis and multi-drug-resistant B. anthracis present a material threat against the United States population, sufficient to affect national security; Whereas there are covered countermeasures to treat, identify, or prevent adverse health consequences or death from exposure to B. anthracis; Whereas such countermeasures, including vaccines, antimicrobials/ antibiotics, and antitoxins for pre-exposure and post-exposure prevention and treatment, diagnostics to identify such exposure, and additional countermeasures for treatment of adverse events arising from use of these countermeasures exist or may be the subject of research and/or development; Whereas such countermeasures may be used and administered in accordance with Federal contracts, cooperative agreements, grants, interagency agreements, and memoranda of understanding, and may also be used and administered at the Regional, State, and local level in accordance with the public health and medical response of the Authority Having Jurisdiction; Whereas, the possibility of governmental program planners obtaining stockpiles from private sector entities except through voluntary means such as commercial sale, donation, or deployment would undermine national preparedness efforts and should be discouraged as provided for in section 319F-3(b)(2)(E) of the Public Health Service Act (42 U.S.C. 247d-6d(b)) (``the Act''); Whereas, immunity under section 319F-3(a) of the Act should be available to governmental program planners for distributions of Covered Countermeasures obtained voluntarily, such as by (1) Donation; (2) commercial sale; (3) deployment of Covered Countermeasures from Federal stockpiles; or (4) deployment of donated, purchased, or otherwise voluntarily obtained Covered Countermeasures from State, local, or private stockpiles; Whereas, the extent of immunity under section 319F-3(a) of the Act afforded to a governmental program planner that obtains covered countermeasures except through voluntary means is not intended to affect the extent of immunity afforded other covered persons with respect to such covered countermeasures. Whereas, in accordance with section 319F-3(b)(6) of the Act, I have considered the desirability of encouraging the design, development, clinical testing or investigation, manufacturing, labeling, distribution, formulation, packaging, marketing, promotion, sale, purchase, donation, dispensing, prescribing, administration, licensing, and use of such countermeasures with respect to the category of disease and population described in sections II and IV below, and have found it desirable to encourage such activities for the covered countermeasures; and Whereas, to encourage the design, development, clinical testing or investigation, manufacturing and product formulation, labeling, distribution, packaging, marketing, promotion, sale, purchase, donation, dispensing, prescribing, administration, licensing, and use of medical countermeasures with respect to the category of disease and population described in sections II and IV below, it is advisable, in accordance with section 319F-3(a) and (b) of the Act, to provide immunity from liability for covered persons, as that term is defined at section 319F-3(i)(2) of the Act, and to include as such covered persons such other qualified persons as I have identified in section VI of this declaration; Therefore, pursuant to section 319F-3(b) of the Act, I have determined there is a credible risk that the threat of exposure of B. anthracis and the resulting disease constitutes a public health emergency.

http://edocket.access.gpo.gov/2008/E8-23547.htm

As many others, I was stunned and amazed by this release. Obviously, this does not bode well, especially considering the computational models coming out of Half Past Human, which show a steadily increasing probability of a United States mass casualty event to coincide with the global economic collapse.

Today , I received inside information regarding a second confirmation, this time via the FDA. I will publish the letter I received in full.

October 3, 2008
Robin Robinson, Ph.D.
Director
Biomedical Advanced Research and Development Authority (BARDA)
330 Independence Avenue SW
Room G640
Washington, DC 20201
Dear Dr. Robinson:
This letter is in response to BARDA's October 1, 2008 submission, as amended,1 requesting that the Food and Drug Administration (FDA) issue an Emergency Use Authorization (EUA) for the pre-event provision and potential use of doxycycline hyclate tablet emergency kits2 for inhalational anthrax, pursuant to section 564 of the Federal Food, Drug, and Cosmetic Act (the Act). Your request is specifically for eligible3 United States Postal Service (USPS) participants in the Cities Readiness Initiative (CRI) (hereinafter USPS participants) and their household members.4
On September 23, 2008, pursuant to section 564(b)(1)(A) of the Act, 21 U.S.C. § 360bbb-3(b)(1)(A), the Secretary of the Department of Homeland Security determined that there is a significant potential for a domestic emergency, involving a heightened risk of attack with a specified biological, chemical, radiological, or nuclear agent or agents--in this case, Bacillus anthracis.5 On October 1, 2008, pursuant to section 564(b) of the Act, and on the basis of such determination, the Secretary of the Department of Health and Human Services declared an emergency justifying the authorization of the emergency use of doxycycline hyclate tablets accompanied by emergency use information subject to the terms of any authorization issued under 21 U.S.C. § 360bbb-3(a).6,7 Having consulted with the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), and having concluded that the criteria for issuance of this authorization under section 564(c) of the Act are met, I am authorizing the emergency use of doxycycline hyclate tablet emergency kits for the post-exposure prophylaxis of inhalational anthrax for eligible USPS participants and their household members,8 subject to the terms of this authorization.
The remainder of this letter is organized into four sections: Background, Criteria for Issuance of Authorization, Scope of Authorization, Conditions of Authorization, and Duration of Authorization.

http://www.mediafire.com/?sharekey=c6c19fa7dc1b85d7ab1eab3e9fa335cab4dedb30e4a27cd7


http://www.fda.gov/cder/drugprepare/EUA_doxycycline.pdf

Please tell me what the hell is going on. Are we to believe Dr. Ivins is plotting from beyond the grave? Or is the criminal syndicate which sent the original anthrax is 2001 still operating within the US government and 'defense' complex?




aka. Who was responsible for the 2001 anthrax attacks?




Astonishingly, a photograph of the specific building in which the Ames strain of hyper-weaponized powdered anthrax was tested appears courtesy of the Federal Emergency Management Agency (FEMA) from one of their educational slide presentations. This photo further establishes, as detailed in BMI's operations description, the direct association between the Dugway Proving Grounds "Life Sciences Facilities" and BMI's "Aerosol Engineering & Biological Sciences Facilities." (38,39)

On May 20, 1998 Dr. Alibekov testified before the Joint Economic Committee of the U.S. Congress as a Program Manager for the Battelle Memorial Institute (BMI)-a leading military contractor and one of few institutional suspects identified by the press. William Broad of the New York Times (Dec. 13, 2001), upon Dr. Horowitz's earlier urging, cited BMI as the chief CIA contractor for project "Clearvision"-an effort to produce the deadliest Ames strain anthrax ever developed. It was hyper-concentrated, silica-laced, electro-magnetized, and extremely transmissible. The facts indicate Dr. Alibekov, one of two leading anthrax experts contracted by the CIA at the time of "Clearvision," may have managed the entire program during which the germ was sent from BMI to the BMI administered and supplied Dugway Proving Grounds in Utah. From here or BMI's anthrax lab in West Jefferson, Ohio, the never-before-seen anthrax weapon was transferred to envelopes and mailed from four locations including Trenton, N.J. and St. Petersburg, FL in early October, 2001. The mailings killed five people while scores of others were victimized by the ensuing fright and toxic side effects from taking CIPRO-the "anthrax antibiotic," according to experts and news reports.

More suspicious ties to the Russian defector and Hadron Advanced Biosystems were realized when investigators learned of the second leading BMI and CIA anthrax contractor, and close personal friend of Dr. Alibekov, Dr. William C. Patrick, III. Suspiciously, Dr. Alibekov and BMI had contracted with this anthrax ace in the Spring of 1998 to predict the dispersal and damage capability of mailing such a hyper-weaponized germ much like the one sent to select members of the media and legislators on Capitol Hill.

...

The three independent investigators each cite economic and political motives for the targeted anthrax mailings. Given the high grade and technical difficulty in producing and handling this grade of anthrax, they reasoned, "white collar criminals" with access to military or pharmaceutical labs most likely acted on behalf of those who benefited most from the attacks and ensuing fright. Hadron and its affiliates, including DynCorp and BMI, lead the pack of corporate and institutional suspects, the investigators say. A revelatory organizational chart prepared by Dr. Horowitz depicting these corporate and institutional suspects was mailed to more than 1,500 FBI agents late last year along with an extensive 25-page report still available over the Internet (link to http://www.tetrahedron.org/articles/anthrax/anthrax_espionage.html)

Logically, the three investigators reasoned, the media was initially targeted to sway public opinion in support of government orders worth billions of dollars for hyped vaccines and drugs, much of which benefited Hadron, DynCorp, BMI and their directors. DynCorp was the major military and intelligence provider awarded $322 million to develop, produce, and store anthrax and smallpox vaccines for the nation. BMI, a leading defense and energy industry contractor, directed the US military's Joint Vaccine Acquisitions Program. Bioport, LLC became a leading beneficiary.

http://www.tetrahedron.org/news/NR020830.html

May you live in interesting times. And if this really goes down, make sure you point the fingers at those responsible: Battelle Memorial Institute, Dyncorp, Bioport, Hadron, and the others associated with this criminal syndicate.